You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 4, 2024

DECLOMYCIN Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Declomycin patents expire, and what generic alternatives are available?

Declomycin is a drug marketed by Lederle and Corepharma and is included in three NDAs.

The generic ingredient in DECLOMYCIN is demeclocycline hydrochloride. There are eleven drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the demeclocycline hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Declomycin

A generic version of DECLOMYCIN was approved as demeclocycline hydrochloride by AMNEAL PHARM on February 27th, 2008.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for DECLOMYCIN?
  • What are the global sales for DECLOMYCIN?
  • What is Average Wholesale Price for DECLOMYCIN?
Drug patent expirations by year for DECLOMYCIN
Drug Prices for DECLOMYCIN

See drug prices for DECLOMYCIN

Recent Clinical Trials for DECLOMYCIN

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Massachusetts General HospitalPhase 1

See all DECLOMYCIN clinical trials

US Patents and Regulatory Information for DECLOMYCIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lederle DECLOMYCIN demeclocycline hydrochloride CAPSULE;ORAL 050262-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Corepharma DECLOMYCIN demeclocycline hydrochloride TABLET;ORAL 050261-002 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Lederle DECLOMYCIN demeclocycline hydrochloride SYRUP;ORAL 050257-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.